Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Edwards Lifesciences
(NY:
EW
)
65.77
+0.36 (+0.55%)
Official Closing Price
Updated: 4:10 PM EDT, Sep 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Edwards Lifesciences
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
July 25, 2024
Pre-market stock movers are a hot topic on Thursday morning and we have all of the latest news traders need to know about them!
Via
InvestorPlace
Nasdaq, S&P Futures Slide On More Negative Tech Tidings As Focus Shifts To Q2 GDP Data: Strategist Says Trump Trades May Not Work Even If Ex-President Retakes White House
July 25, 2024
Sentiment continues to be jittery, with the major index futures priming for a lower opening on Thursday as traders look ahead to the first read of second-quarter GDP data and more earnings. The tech...
Via
Benzinga
Topics
Government
Stocks
Exposures
Political
US Equities
P/E Ratio Insights for Edwards Lifesciences
July 11, 2024
Via
Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $33,000 Today
July 05, 2024
Via
Benzinga
The Analyst Landscape: 13 Takes On Edwards Lifesciences
July 02, 2024
Via
Benzinga
Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
July 25, 2024
Via
Benzinga
EW Stock Earnings: Edwards Lifesciences Beats EPS, Misses Revenue for Q2 2024
July 24, 2024
EW stock results show that Edwards Lifesciences beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Edwards Stock Plummets After Medtech Slashes Its TAVR Outlook For The Year
July 24, 2024
The company now expects full-year sales in its TAVR division to climb 5% to 7%.
Via
Investor's Business Daily
US Stocks Could Open Sharply Lower As Tesla, Alphabet Earnings Offer No Cheer: Analyst Says This Bodes Well For Small-Caps, 'Only Takes A Small Spark To Ignite A Powerful Move'
July 24, 2024
Wall Street is gearing up for a negative start on Thursday, as traders mull over earnings from Tesla, Inc. (NASDAQ:TSLA) and Alphabet, Inc.
Via
Benzinga
Peering Into Edwards Lifesciences's Recent Short Interest
June 21, 2024
Via
Benzinga
$100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth This Much Today
June 20, 2024
Via
Benzinga
US Stocks Tumble, Magnificent 7 Wipe Out $570 Billion As Mega-Tech Earnings Disappoint, VIX Spikes: What's Driving Markets Wednesday?
July 24, 2024
Wall Street experienced a turbulent session on Wednesday, with the S&P 500 index heading toward its worst performance in over a year and the tech-focused Nasdaq 100 eyeing its fifth decline in the last...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
UnitedHealth, Edwards Lifesciences, First Citizens Bank And More: CNBC's 'Final Trades'
July 11, 2024
UnitedHealth Group was declared a "solid" healthcare company on CNBC. Cantor Fitzgerald analyst Sarah James maintains a price target of $591.
Via
Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,900 Today
May 30, 2024
Via
Benzinga
What Analysts Are Saying About Edwards Lifesciences Stock
May 30, 2024
Via
Benzinga
Looking Into Edwards Lifesciences's Recent Short Interest
May 29, 2024
Via
Benzinga
Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally
July 21, 2024
The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season.
Via
Benzinga
Assessing Edwards Lifesciences: Insights From 11 Financial Analysts
May 07, 2024
Via
Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $16,000 Today
April 26, 2024
Via
Benzinga
Stock Market Revs To Highs On Nvidia, CrowdStrike, Yields: Weekly Review
June 07, 2024
The Nasdaq and S&P 500 hit record highs, but small caps retreated.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
BD Bolsters Portfolio With $4.2B Cash Deal For Edwards Lifesciences' Critical Care Group: Details
June 03, 2024
BD (Becton, Dickinson and Company) will acquire Edwards Lifesciences' Critical Care product group for $4.2 billion in cash. This acquisition enhances BD's portfolio with advanced AI-enabled monitoring...
Via
Benzinga
Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal
June 03, 2024
Edwards Lifesciences stock rallied Monday on medtech giant Becton Dickinson's plan to buy a key division for $4.2 billion.
Via
Investor's Business Daily
Here's How Much $1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today
May 15, 2024
Via
Benzinga
Decoding Edwards Lifesciences's Options Activity: What's the Big Picture?
April 25, 2024
Via
Benzinga
Indian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint
May 14, 2024
Edwards Lifesciences faces EU antitrust complaint from Meril over patent disputes, intensifying regulatory scrutiny. Recent actions aim to ensure fair competition, affordability, as Meril alleges...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Is It Time To Get Defensive With Healthcare Stocks?
May 13, 2024
Based in Irvine, California, Edwards Lifesciences is a prominent American medical technology firm.
Via
Talk Markets
Jim Cramer: These Airline Stocks 'Trade Wildly,' Edwards Lifesciences 'At The Right Level To Buy'
May 01, 2024
Cramer likes Delta Air Lines, United Airlines Holdings. "Now, remember, they're very inexpensive stocks, but they trade wildly. But I do like Delta," he added.
Via
Benzinga
Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review
April 26, 2024
Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser.
Via
Investor's Business Daily
EW Stock Earnings: Edwards Lifesciences Beats EPS, Beats Revenue for Q1 2024
April 25, 2024
EW stock results show that Edwards Lifesciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff
April 25, 2024
The company also raised its outlook for the year and now expects 8% to 10% sales growth.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.